logo

For the Inventor, By the Inventor

Bagsvaerd, Denmark

Christian Isak Joergensen

This inventor holds 15 USPTO granted patents and 2 published patent applications and 6 EPO patents. Top assignees: Novozymes A/s, Novozymes, Inc.. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Isak Joergensen. Retrieved from https://idiyas.com/inventor/christian-isak-joergensen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 93.3

 

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 28(Granted Patents)


Company Filing History:

goldMedal15 out of 1,426 
 
Novozymes A/s
 patents
silverMedal2 out of 384 
 
Novozymes, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents
1. 12590273 - STABILIZED GLYCOSIDE HYDROLASE VARIANTS (2026-03-31),
2. 12509671 - MANNANASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME (2025-12-30),
3. 12497606 - MANNANASE VARIANTS AND POLYNUCLEOTIDES ENCODING SAME (2025-12-16),
4. 12391934 - Stabilized cellulase variants (2025-08-19),
5. 11566239 - Stabilized cellulase variants (2023-01-31),
6. 10954499 - Process for treating arabinoxylan-containing substrate (2021-03-23),
7. 10851356 - Method for modifying characteristics of a lipase (2020-12-01),
8. 10233434 - Process for treating an arabinoxylan-containing substrate (2019-03-19),
9. 10221404 - Method for modifying characteristics of a lipase (2019-03-05),
10. 9822349 - Nucleic acids encoding arabinofuranosidase (2017-11-21),
11. 9506049 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2016-11-29),
12. 9428741 - Nucleic acid construct with gene encoding an arabinofuranosidase polypeptide and methods of using same (2016-08-30),
13. 8835717 - Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same (2014-09-16),
14. 8288510 - Isolated peptides having phospholipase inhibitory activity (2012-10-16),
15. 7993890 - Hydrolysis of arabinoxylan (2011-08-09),

Title: The Innovations of Christian Isak Joergensen

Introduction

Christian Isak Joergensen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of cellulase variants. With a total of 15 patents to his name, Joergensen's work has had a substantial impact on various industrial applications.

Latest Patents

Among his latest patents, Joergensen has disclosed variants of a cellulase that exhibit improved stability in the presence of a protease. These stabilized cellulase variants are particularly useful in laundry applications, enhancing the effectiveness of cleaning products. His innovative approach to enzyme stability has opened new avenues for research and commercial use.

Career Highlights

Throughout his career, Joergensen has worked with prominent companies in the biotechnology sector, including Novozymes A/S and Novozymes, Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Joergensen has collaborated with several talented individuals, including Hanne Risbjerg Soerensen and Christel Thea Joergensen. These partnerships have fostered a creative environment that has led to the development of innovative solutions in enzyme technology.

Conclusion

Christian Isak Joergensen's contributions to the field of biotechnology, particularly through his patented cellulase variants, demonstrate his commitment to innovation. His work continues to influence the industry and inspire future advancements in enzyme applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…